Hadassah Medical Center

Israeli companies present breakthrough medical technologies - IMPROVATE Life-Saving Technologies Conference: Cell therapies, bio-engineering, big-data analytics creating future of medicine

Retrieved on: 
Thursday, July 29, 2021

Prof. Ze'ev Rotstein, Director of Hadassah Medical Center, addressed the conference on how better data creates better care.

Key Points: 
  • Prof. Ze'ev Rotstein, Director of Hadassah Medical Center, addressed the conference on how better data creates better care.
  • Big data is not only the clinical data of the patients, but we are deepening our understanding of all the genomics.
  • Former Bulgarian President and IMPROVATE advisory board member Rosen Plevneliev said the European market holds huge opportunities for Israeli companies.
  • IMedishas developed Duali-Q, a revolutionary medical innovation that promotes early detection of cancer and other life-threatening diseases using AI technology.

Major Healthcare Providers in Israel Choose Sectra's Digital Pathology Solution for Full-scale Primary Diagnostics

Retrieved on: 
Thursday, July 9, 2020

It reduces variation and increases efficiency in primary diagnostics, thereby improving fields such as cancer care.

Key Points: 
  • It reduces variation and increases efficiency in primary diagnostics, thereby improving fields such as cancer care.
  • The systems at Hadassah Medical Center and Assuta Medical Center were sold by Sectra's distribution partner in Israel, Medi-Far Healthcare Solutions.
  • Hadassah Medical Center performs about 40,000 pathology examinations per year across its two university hospitals and 120 clinics located in Jerusalem.
  • The digital solution provides pathologists with assistance at critical decision points, such as grading or performing more precise measurements.

Major Healthcare Providers in Israel Choose Sectra's Digital Pathology Solution for Full-scale Primary Diagnostics

Retrieved on: 
Thursday, July 9, 2020

It reduces variation and increases efficiency in primary diagnostics, thereby improving fields such as cancer care.

Key Points: 
  • It reduces variation and increases efficiency in primary diagnostics, thereby improving fields such as cancer care.
  • The systems at Hadassah Medical Center and Assuta Medical Center were sold by Sectra's distribution partner in Israel, Medi-Far Healthcare Solutions.
  • Hadassah Medical Center performs about 40,000 pathology examinations per year across its two university hospitals and 120 clinics located in Jerusalem.
  • The digital solution provides pathologists with assistance at critical decision points, such as grading or performing more precise measurements.

Nanox Signs Agreement With Hadassah Medical Organization for the Development of Novel Early-detection Protocols for the Nanox.ARC

Retrieved on: 
Monday, April 27, 2020

Hadassah and its world-class medical facilities and staff were Nanoxs first choice for whom to collaborate with on innovative life-saving medical imaging procedures via full-body scans.

Key Points: 
  • Hadassah and its world-class medical facilities and staff were Nanoxs first choice for whom to collaborate with on innovative life-saving medical imaging procedures via full-body scans.
  • The scans will be delivered globally to increase accessibility to medical imaging for all socio-economic levels.
  • Hadassah treats one million patients a year regardless of race, religion, or nationality, and it is that same spirit of compassion and medical democratization that we see in Nanox, says Erez Meltzer, Chairman of the Hadassah Medical Organization.
  • Hadassah practices translational medicine, combining state-of-the-art medical and surgical care with top-level interdisciplinary research and development activity.

BioTheryX Appoints Professor Yinon Ben-Neriah, M.D., Ph.D., to its Scientific Advisory Board

Retrieved on: 
Friday, March 6, 2020

Dr. BenNeriah is Professor of Immunology and Cancer Research at the Lautenberg Center of Immunology of the Hebrew University, Hadassah Medical School in Jerusalem, Israel.

Key Points: 
  • Dr. BenNeriah is Professor of Immunology and Cancer Research at the Lautenberg Center of Immunology of the Hebrew University, Hadassah Medical School in Jerusalem, Israel.
  • Dr. Ben-Neriah said, "I am honored and proud to be joining the SAB of BioTheyrX.
  • Having the privilege of interacting with the entire team for the past 5 years, I must say it is truly a visionary company.
  • It has potential applicability to a broad range of diseases, including targets that have to date been considered 'undruggable'.